Mike Carruthers Email & Phone Number
@edgewisetx.com
1 phone found area 303
LinkedIn matched
Who is Mike Carruthers? Overview
A concise factual answer block for searchers comparing this professional profile.
Mike Carruthers is listed as CFO Edgewise Therapeutics at Edgewise Therapeutics, based in Austin, Texas, United States. AeroLeads shows a work email signal at edgewisetx.com, phone signal with area code 303, and a matched LinkedIn profile for Mike Carruthers.
Mike Carruthers previously worked as Chief Financial Officer at Edgewise Therapeutics and BOD member and audit chair at Elevation Oncology. Mike Carruthers holds Mba from University Of Chicago.
Email format at Edgewise Therapeutics
This section adds company-level context without repeating Mike Carruthers's masked contact details.
AeroLeads found 1 current-domain work email signal for Mike Carruthers. Compare company email patterns before reaching out.
About Mike Carruthers
Financial executive with over 25 years experience in biotechnology and medical devices. Helped four companies become and operate as public companies through IPO or reverse merger and raised over $1B in private and public funding using both debt and equity vehicles. M&A transactions including both acquiring and selling whole companies or divisions. Enjoy hands-on involvement in discovery and development operations including clinical strategy and pre-market positioning.
Listed skills include Financial Analysis, Sec Filings, Financial Reporting, Pharmaceutical Industry, and 19 others.
Mike Carruthers's current company
Company context helps verify the profile and gives searchers a useful next step.
Mike Carruthers work experience
A career timeline built from the work history available for this profile.
Bod Member And Audit Chair
Current
Bod Member And Audit Chair
CurrentFractional Cfo To Biotech
Fractional CFO for biotech and related companies including Brickell Bio, OnKure Therapeutics and ClinOne
Cfo & Interim President
Nivalis Therapeutics, Inc., (Nasdaq: NVLS) is a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of product candidates for patients with cystic fibrosis (CF). CF is a life-shortening genetic disease. Its lead product candidate is N91115, a small molecule that is in clinical development, which addresses a defect in cystic fibrosis transmembrane conductance regulator (CFTR), resulting from mutations in the CFTR gene. The company was formerly known as N30 Pharmaceuticals, Inc. and changed its name to Nivalis Therapeutics, Inc. in February 2015. Nivalis Therapeutics, Inc. was founded in 2007 and is headquartered in Boulder, Colorado.
Cfo
Array BioPharma Inc.(Nasdaq: ARRY), is a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule drugs to treat patients with cancer in North America, Europe, and the Asia Pacific. The companys drugs in Phase III clinical trials include Binimetinib and Encorafenib for the treatment of cancer. Its drug candidates in Phase II clinical trials include Filanesib, a kinesin spindle protein inhibitor for multiple myeloma; ARRY-797, a p38 inhibitor for Lamin A/C-related dilated cardiomyopathy; ASC08/Danoprevir, a protease inhibitor for Hepatitis C virus; ASLAN001/ARRY-543, a pan-HER inhibitor for gastric or breast cancer; Ipatasertib/GDC-0068, an AKT inhibitor for cancer; Motolimod/VTX-2337, a toll-like receptor for cancer; and LY2606368, a chk-1 inhibitor for cancer. The companys Phase Ib drug candidate comprises GDC-0575, a chk-1 inhibitor for cancer; and ONT-380/ARRY-380, a HER2 inhibitor for breast cancer, as well as Phase I drug candidate includes GDC-0994, an ERK inhibitor for cancer and LOXO-101, a PanTrk inhibitor for cancer. Array BioPharma Inc. has collaboration agreements with Biogen Idec MA Inc.; Array and Celgene Corporation and Celgene Alpine Investment Co., LLC; Genentech, Inc.; Loxo Oncology, Inc.; Novartis International Pharmaceutical Ltd.; and Oncothyreon Inc. The company was founded in 1998 and is headquartered in Boulder, Colorado.
Cfo
Controller/Treasurer
Mike Carruthers education
Mba
Bs, Accounting
Accounting
Education record
Frequently asked questions about Mike Carruthers
Quick answers generated from the profile data available on this page.
What company does Mike Carruthers work for?
Mike Carruthers works for Edgewise Therapeutics.
What is Mike Carruthers's role at Edgewise Therapeutics?
Mike Carruthers is listed as CFO Edgewise Therapeutics at Edgewise Therapeutics.
What is Mike Carruthers's email address?
AeroLeads has found 1 work email signal at @edgewisetx.com for Mike Carruthers at Edgewise Therapeutics.
What is Mike Carruthers's phone number?
AeroLeads has found 1 phone signal(s) with area code 303 for Mike Carruthers at Edgewise Therapeutics.
Where is Mike Carruthers based?
Mike Carruthers is based in Austin, Texas, United States while working with Edgewise Therapeutics.
What companies has Mike Carruthers worked for?
Mike Carruthers has worked for Edgewise Therapeutics, Elevation Oncology, Onkure Therapeutics, Sun Dog Springs Group, and Nivalis Therapeutics, Inc..
How can I contact Mike Carruthers?
You can use AeroLeads to view verified contact signals for Mike Carruthers at Edgewise Therapeutics, including work email, phone, and LinkedIn data when available.
What schools did Mike Carruthers attend?
Mike Carruthers holds Mba from University Of Chicago.
What skills is Mike Carruthers known for?
Mike Carruthers is listed with skills including Financial Analysis, Sec Filings, Financial Reporting, Pharmaceutical Industry, Accounting, Financial Modeling, Biotechnology, and Strategic Planning.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial